We are live on ! Find out more
RCKT icon

Rocket Pharmaceuticals
RCKT

173 hedge funds and large institutions have $315M invested in Rocket Pharmaceuticals in 2025 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 61 increasing their positions, 62 reducing their positions, and 50 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

98% more call options, than puts

Call options by funds: $2.87M | Put options by funds: $1.45M

35% more capital invested

Capital invested by funds: $233M → $315M (+$81.8M)

0.53% more ownership

Funds ownership: 88.98% → 89.52% (+0.53%)

2% less repeat investments, than reductions

Existing positions increased: 61 | Existing positions reduced: 62

12% less funds holding

Funds holding: 196 → 173 (-23)

44% less first-time investments, than exits

New positions opened: 28 | Existing positions closed: 50

Holders
173
Holders Change
-23
Holders Change %
-11.73%
% of All Funds
2.27%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
28
Increased
61
Reduced
62
Closed
50
Calls
$2.87M
Puts
$1.45M
Net Calls
+$1.42M
Net Calls Change
+$925K

Top Buyers

1
MAM
Monaco Asset Management
Monaco
+$7.68M
2
Citadel Advisors
Citadel Advisors
Florida
+$4.77M
3
Millennium Management
Millennium Management
New York
+$3.85M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$3.77M
5
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$3.72M

Top Sellers

1
Toronto Dominion Bank
Toronto Dominion Bank
Ontario, Canada
-$2.69M
2
CSS
Cubist Systematic Strategies
Connecticut
-$1.76M
3
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
-$1.68M
4
WP
Woodline Partners
California
-$1.6M
5
N
Nuveen
North Carolina
-$1.51M
Name Holding Trade Value Shares
Change 		Change in
Stake
Northern Trust
26
Northern Trust
Illinois
$2.14M -$140K -44,324 -6%
Federated Hermes
27
Federated Hermes
Pennsylvania
$2.05M +$10.3K +3,264 +0.5%
Walleye Capital
28
Walleye Capital
New York
$2.04M +$156K +49,482 +9%
ACM
29
ADAR1 Capital Management
Texas
$1.88M +$945K +300,000 +109%
Dimensional Fund Advisors
30
Dimensional Fund Advisors
Texas
$1.81M -$13K -4,127 -0.7%
UBS Group
31
UBS Group
Switzerland
$1.74M -$956K -303,516 -36%
Bank of America
32
Bank of America
North Carolina
$1.68M +$151K +47,816 +10%
Jane Street
33
Jane Street
New York
$1.58M +$1.39M +440,213 +994%
Squarepoint
34
Squarepoint
New York
$1.43M +$776K +246,361 +128%
SPS
35
Susquehanna Portfolio Strategies
Pennsylvania
$1.42M – – –
PFM
36
Privium Fund Management
Netherlands
$1.41M – – –
MCM
37
M28 Capital Management
Connecticut
$1.26M – – –
BNP Paribas Financial Markets
38
BNP Paribas Financial Markets
France
$1.23M -$243K -77,056 -17%
Fidelity Investments
39
Fidelity Investments
Massachusetts
$1.02M +$144K +45,652 +17%
HWAM
40
Hennion & Walsh Asset Management
New Jersey
$996K +$98.2K +31,179 +11%
VC
41
Voss Capital
Texas
$978K -$630K -200,000 -40%
Royal Bank of Canada
42
Royal Bank of Canada
Ontario, Canada
$915K -$306K -97,087 -26%
PP
43
PDT Partners
New York
$867K – – –
Los Angeles Capital Management
44
Los Angeles Capital Management
California
$862K +$597K +189,514 +253%
Bank of New York Mellon
45
Bank of New York Mellon
New York
$800K +$42K +13,327 +6%
ECM
46
ExodusPoint Capital Management
New York
$790K +$243K +77,147 +47%
GCP
47
GSA Capital Partners
United Kingdom
$731K +$589K +187,037 +502%
Invesco
48
Invesco
Georgia
$725K +$351K +111,449 +100%
JF
49
Jump Financial
Illinois
$724K -$678K -215,257 -49%
Acadian Asset Management
50
Acadian Asset Management
Massachusetts
$681K -$277K -88,059 -30%
1
2
3 4 5

RCKT Hedge Fund Activity: Q3 2025 in Review

173 of the 7,619 institutional investors tracked by Wall St. Rank reported a position in Rocket Pharmaceuticals (RCKT) for Q3 2025, worth a combined $315M — up 35% from $233M a quarter earlier.

Sellers outnumbered buyers: 50 funds closed out of RCKT and 28 opened new positions — a net loss of 22 holders — while 62 trimmed existing stakes and 61 added.

The largest buyer was Monaco Asset Management, adding an estimated $7.68M. The largest seller was Toronto Dominion Bank, exiting entirely with an estimated $2.69M sold.

  • 173 institutional investors held Rocket Pharmaceuticals (RCKT) as of Q3 2025, down from 196 in Q2 2025.
  • Funds reported $315M of Rocket Pharmaceuticals stock for Q3 2025, up 35% quarter-over-quarter.
  • 28 funds opened new Rocket Pharmaceuticals positions in Q3 2025 and 50 closed out, a net change of -22 holders.
  • The largest Rocket Pharmaceuticals buyer in Q3 2025 was Monaco Asset Management, an estimated $7.68M added.
  • The largest Rocket Pharmaceuticals seller in Q3 2025 was Toronto Dominion Bank, an estimated $2.69M sold.

Based on aggregated 13F filings for Q3 2025.